
Avista Capital Closes $1.5B Healthtech Fund
Avista Capital Partners, a NY-based healthcare-focused private equity firm, announced the final closing of its sixth fund, Avista Healthcare Partners VI, at $1.5 billion. The fund surpassed its $1.25 billion target,
The fund builds on the firm’s strategy of investing in high-growth middle-market products and healthtech companies in North America and Europe.
“The closing of Fund VI is an endorsement of our long-held strategy of identifying and accelerating growth-oriented healthcare businesses with strong secular tailwinds,” said David Burgstahler, Avista CEO.
The firm’s core healthcare sub-sectors include outsourced pharma & medtech services, consumer healthcare, medical devices, specialty & generic pharmaceuticals, distribution and diagnostics, and healthcare technology.
Fund VI is the third dedicated healthcare fund for Avista and has already made five healthcare platform investments.
Founded in 2005, Avista Capital has invested more than $8 billion in over 45 growth-oriented healthcare businesses globally.